$62.32
-4.53-6.78%
At close: -
$63.00
0.681.09%
After Hours: 7:55 PM EDT
Comments
Loading...
GeneDx Holdings Stock Guidance | NASDAQ:WGS | Benzinga
GeneDx Holdings issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/30/2025 | WGS | GeneDx Holdings | FY | 2025 | — | — | — | $360.00M | $375.00M | $358.62M | Get Alert |
| 02/18/2025 | WGS | GeneDx Hldgs | FY | 2025 | — | — | — | $350.00M | $360.00M | $338.77M | Get Alert |
| 01/13/2025 | WGS | GeneDx Hldgs | Q4 | 2024 | — | — | — | $92.00M | — | $80.22M | Get Alert |
| 01/13/2025 | WGS | GeneDx Hldgs | FY | 2024 | — | — | — | $299.00M | — | $288.20M | Get Alert |
| 10/29/2024 | WGS | GeneDx Hldgs | FY | 2024 | — | — | — | $284.00M | $290.00M | $263.37M | Get Alert |
| 07/30/2024 | WGS | GeneDx Hldgs | FY | 2024 | — | — | — | $255.00M | $265.00M | $242.39M | Get Alert |
| 04/29/2024 | WGS | GeneDx Hldgs | FY | 2024 | — | — | — | $235.00M | $245.00M | $226.10M | Get Alert |
| 02/20/2024 | WGS | GeneDx Hldgs | FY | 2024 | — | — | — | $220.00M | $230.00M | $227.30M | Get Alert |
| 01/08/2024 | WGS | GeneDx Hldgs | FY | 2023 | — | — | — | $203.00M | — | $188.30M | Get Alert |
| 01/08/2024 | WGS | GeneDx Hldgs | Q4 | 2023 | — | — | — | $58.00M | — | $49.06M | Get Alert |
| 10/30/2023 | WGS | GeneDx Hldgs | FY | 2023 | — | — | — | $187.00M | $192.00M | $207.59M | Get Alert |
| 08/08/2023 | WGS | GeneDx Hldgs | FY | 2023 | — | — | — | $205.00M | $220.00M | $208.23M | Get Alert |
| 05/09/2023 | WGS | GeneDx Hldgs | FY | 2023 | — | — | — | $205.00M | $220.00M | $205.40M | Get Alert |
| 03/14/2023 | WGS | GeneDx Hldgs | FY | 2023 | — | — | — | $205.00M | $220.00M | $217.84M | Get Alert |
FAQ
What is the most recent guidance for GeneDx Holdings (WGS)?
There have been no specific sales or earnings guidance reported for GeneDx Holdings in recent months.
Browse guidance and forecast on all stocks.
